Results 31 to 40 of about 1,484 (134)

Performance comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in detecting Mycobacterium tuberculosis infection among HIV patients in China [PDF]

open access: yesPeerJ
Introduction No direct comparative study assessing QuantiFERON-TB Gold In-Tube (QFT-GIT) and QuantiFERON-TB Gold Plus (QFT-Plus) for Mycobacterium tuberculosis infection among persons living with HIV (PLHIV) in China has been conducted.
Peng Lu   +10 more
doaj   +2 more sources

CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis

open access: yesScientific Reports, 2020
A significantly negative reversion in the QuantiFERON-TB Gold In-tube (QFT-GIT) test is reported in patients on dialysis, which makes the results unreliable.
Ping-Huai Wang   +8 more
doaj   +1 more source

In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production

open access: yesLife, 2022
Increased rates of indeterminate QuantiFERON-TB Gold Plus Assay (QFT-Plus) were demonstrated in patients hospitalized with Coronavirus Disease (COVID)-19.
Alessandra Imeneo   +20 more
doaj   +1 more source

The Pitfalls of Mining for QuantiFERON Gold in Severely Ill Patients With COVID-19

open access: yesMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2022
Objective: To assess the proportion of indeterminate QuantiFERON-TB Gold Plus (QFT-Plus) results in patients admitted for severe coronavirus disease 2019 (COVID-19) pneumonia and evaluate the factors associated with indeterminate QFT-Plus results ...
Melissa P. Cortes, MD   +11 more
doaj   +1 more source

Sensitivity and characteristics associated with positive QuantiFERON-TB Gold-Plus assay in children with confirmed tuberculosis.

open access: yesPLoS ONE, 2019
BACKGROUND:Although QuantiFERON-TB Gold Plus (QFT-Plus), a new interferon-gamma release assay, has shown good performance in adults, little data is available in children. METHODS:De-identified data from TB-suspected patients age
Duc T Nguyen   +11 more
doaj   +1 more source

Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids)

open access: yesInternational Journal of Infectious Diseases, 2023
: Objectives: To determine whether weekly oral supplementation with 10,000 IU vitamin D3 for 3 years reduces the risk of sensitization to M. tuberculosis in South African schoolchildren aged 6-11 years with negative QuantiFERON-tuberculosis (TB) Gold ...
Keren Middelkoop   +15 more
doaj   +1 more source

Prevalence of latent tuberculosis infection among foreign students in Lübeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus

open access: yesJournal of Occupational Medicine and Toxicology, 2017
Background The tuberculosis (TB) incidence rate in foreign-born individuals has been increasing in Germany in recent years. Foreign students may be an important source of latent tuberculosis infection (LTBI) in low-incidence countries.
Elia Noemi Gallegos Morales   +4 more
doaj   +1 more source

Discordance of 3rd and 4th generation QuantiFERON-TB Gold assays by pregnancy stages in India

open access: yesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases
Background: Pregnancy and HIV affect CD4+ T lymphocytes and impact performance of QuantiFERON-TB Gold (QFT). We compared the results of QFT with QuantiFERON-TB Gold Plus (QFT-Plus), which also measures CD8+ responses to TB antigens, during pregnancy and ...
Vandana Kulkarni   +12 more
doaj   +1 more source

Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study

open access: yesPLoS ONE, 2023
Background Interferon-y Release Assays (IGRA) reversions have been reported in different clinical scenarios for the diagnosis of tuberculosis (TB) infection.
Sandra Pérez-Recio   +19 more
doaj  

First evaluation of the performance of portable IGRA, QIAreach® QuantiFERON®-TB in intermediate TB incidence setting.

open access: yesPLoS ONE, 2023
Diagnosis and treatment of tuberculosis infection (TBI) are the core elements of tuberculosis elimination. Interferon gamma release assays have advantages over the tuberculin skin test, although their implementation in low-resource settings is ...
Zirwatul Adilah Aziz   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy